Advanced search
Publication Cover
Expert Review of Anticancer Therapy Volume 21, 2021 - Issue 12
Submit an article Journal homepage
4,490
Views
5
CrossRef citations to date
0
Altmetric
Drug Profile

Tackling metastatic triple-negative breast cancer with sacituzumab govitecan

Anna R Schreibera Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO, USAORCID Iconhttps://orcid.org/0000-0003-2136-2476View further author information
ORCID Icon,
Michelle Andressb Department of Pharmacy, University of Colorado Anschutz Medical Campus, Aurora, CO, USAView further author information
&
Jennifer R Diamonda Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO, USACorrespondence[email protected]
View further author information
Pages 1303-1311 | Received 08 Sep 2021, Accepted 11 Oct 2021, Published online: 22 Oct 2021

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Anna R. Schreiber, Cindy L. O’Bryant, Peter Kabos & Jennifer R. Diamond. (2023) The emergence of targeted therapy for HER2-low triple-negative breast cancer: a review of fam-trastuzumab deruxtecan. Expert Review of Anticancer Therapy 23:10, pages 1061-1069.
Read now
Lianqi Liu, Fei Xie, Dian Xiao, Xin Xu, Zheng Su, Yanming Wang, Shiyong Fan, Xinbo Zhou & Song Li. (2021) Synthesis and evaluation of highly releasable and structurally stable antibody-SN-38-conjugates. Drug Delivery 28:1, pages 2603-2617.
Read now

Articles from other publishers (3)

Alexandra Stefan, Alexander König, Nadia Harbeck & Rachel Würstlein. (2023) Supportivtherapie bei Brustkrebs. Im Fokus Onkologie 26:2, pages 35-42.
Crossref
Avinash Khadela, Shruti Soni, Aayushi C. Shah, Aanshi J. Pandya, Kaivalya Megha, Nirjari Kothari & Avinash CB. (2022) Unveiling the antibody–drug conjugates portfolio in battling Triple-negative breast cancer: Therapeutic trends and Future horizon. Medical Oncology 40:1.
Crossref
Nami Yamashita & Donald Kufe. (2022) Addiction of Cancer Stem Cells to MUC1-C in Triple-Negative Breast Cancer Progression. International Journal of Molecular Sciences 23:15, pages 8219.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.